Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garnick

Showing results (161-170 of 305) with videos related to

Pageof 31
Sort By:
Hospital & Community Psychiatry|December 1, 1994
Characteristics of private-sector managed care for mental health and substance abuse treatmentD W Garnick, A M Hendricks, J D Dulski, et al.
Journal of Psychoactive Drugs|March 29, 2017
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014Sharon Reif, Timothy B Creedon, Constance M Horgan, et al.
Urology|March 12, 1998
Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapyA V D'Amico, E Chang, M Garnick, et al.
Journal of Clinical Periodontology|July 3, 1998
Human periodontal ligament fibroblast response to PDGF-BB and IGF-1 application on tetracycline HCI conditioned root surfacesA Y Gamal, J M Mailhot, J J Garnick, et al.
Health Services Research|March 16, 2007
Does type of gatekeeping model affect access to outpatient specialty mental health services?Dominic Hodgkin, Elizabeth L Merrick, Constance M Horgan, et al.
Journal of Periodontology|April 1, 1989
Gingival resistance to probing forces. I. Determination of optimal probe diameterJ G Keagle, J J Garnick, J R Searle, et al.
Journal of Applied Toxicology : JAT|February 24, 2022
Dose and exposure route analyses inform relationships between liver steatosis and 2-amino-2-methyl-1-propanol: Implications for hazard characterizationLindsey Garnick, Christopher Bates, Andrey Massarsky, et al.
The Journal of Urology|October 5, 2023
Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone AntagonistE David Crawford, Jason M Hafron, Frans Debruyne, et al.
Journal of Periodontology|September 1, 1989
Gingival resistance to probing forces. II. The effect of inflammation and pressure on probe displacement in beagle dog gingivitisJ J Garnick, J G Keagle, J R Searle, et al.
Urology|November 20, 2003
An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonistsMichael Koch, Christopher Steidle, Stanley Brosman, et al.
Pageof 31

Showing results (161-170 of 305) with videos related to

Sort By:
Pageof 31
Hospital & Community Psychiatry|December 1, 1994
Characteristics of private-sector managed care for mental health and substance abuse treatmentD W Garnick, A M Hendricks, J D Dulski, et al.
Journal of Psychoactive Drugs|March 29, 2017
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014Sharon Reif, Timothy B Creedon, Constance M Horgan, et al.
Urology|March 12, 1998
Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapyA V D'Amico, E Chang, M Garnick, et al.
Journal of Clinical Periodontology|July 3, 1998
Human periodontal ligament fibroblast response to PDGF-BB and IGF-1 application on tetracycline HCI conditioned root surfacesA Y Gamal, J M Mailhot, J J Garnick, et al.
Health Services Research|March 16, 2007
Does type of gatekeeping model affect access to outpatient specialty mental health services?Dominic Hodgkin, Elizabeth L Merrick, Constance M Horgan, et al.
Journal of Periodontology|April 1, 1989
Gingival resistance to probing forces. I. Determination of optimal probe diameterJ G Keagle, J J Garnick, J R Searle, et al.
Journal of Applied Toxicology : JAT|February 24, 2022
Dose and exposure route analyses inform relationships between liver steatosis and 2-amino-2-methyl-1-propanol: Implications for hazard characterizationLindsey Garnick, Christopher Bates, Andrey Massarsky, et al.
The Journal of Urology|October 5, 2023
Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone AntagonistE David Crawford, Jason M Hafron, Frans Debruyne, et al.
Journal of Periodontology|September 1, 1989
Gingival resistance to probing forces. II. The effect of inflammation and pressure on probe displacement in beagle dog gingivitisJ J Garnick, J G Keagle, J R Searle, et al.
Urology|November 20, 2003
An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonistsMichael Koch, Christopher Steidle, Stanley Brosman, et al.
Pageof 31